by Metagenomic sequencing plays a vital role in understanding the structure of microbial communities and genomes directly recovered from environmental samples without culturing. It allows the study of microbial diversity and the analysis of biological functional pathways.
The Global Metagenomic Sequencing Market Size Is Estimated To Be Valued At US$ 1.41 Bn In 2024 And Is Expected To Exhibit A CAGR Of 17.% Over The Forecast Period 2024-2031.
Key players operating in the global metagenomic sequencing market are Illumina, QIAGEN, Thermo Fisher Scientific, Oxford Nanopore Technologies, BGI Group, Perkinelmer, GENEWIZ, Macrogen, Zymo Research, Diversigen, Microsynth AG, Baseclear, MR DNA (Molecular Research), Eurofins Scientific, Novogene Corporation, Nugen Technologies, Takara Bio, Swift Biosciences, New England Biolabs, And Cosmosid. Metagenomic sequencing is gaining traction in healthcare for applications such as microbiome studies, pathogen detection, and disease diagnostics. It is also being increasingly used in environmental research for monitoring microbial communities and pollution assessment in soil, oceans, and industrial wastes.
Key Takeaways
Key players: Key players in the global metagenomic sequencing market include Illumina, QIAGEN, Thermo Fisher Scientific, Oxford Nanopore Technologies and BGI Group.
Key Opportunities: Increasing R&D investments and government funding for microbiome research, rise in infectious diseases, growth of precision medicine and point-of-care diagnostics provide lucrative growth opportunities.
Global Expansion: Key players are expanding their geographic presence and service portfolios through partnerships and acquisitions. Increased accessibility of metagenomic sequencing technologies across emerging markets will drive the market during the forecast period.
Market Drivers
Rising application of metagenomic techniques in healthcare and environmental research is the biggest driver for market growth. It is enabling advances in fields such as disease diagnosis, drug discovery, bioremediation, water quality monitoring, and climate change research. Growing collaboration between academia and industry to develop diagnostic and therapeutic interventions is further fueling the adoption of metagenomic sequencing.
Pest Analysis
Political: Regulations related to clinical sequencing and research could impact the market. Ethical issues regarding genetic sequencing are also considered by regulatory bodies.
Economic: Rising healthcare costs drive demand for cost-effective diagnostic and disease management techniques. Funding availability influences research spending and technology adoption.
Social: Increased awareness of personalized medicine and the role of microbiome in health promotes individual sequencing adoption. Privacy and security of genetic data are concerns.
Technological: Continuous improvements in high-throughput sequencing platforms and bioinformatics solutions enhance clinical applicability and drive down costs. Cloud computing facilitates large-scale data analysis. Miniaturization aids point-of-care applications.
The Americas region currently accounts for the largest share of the global metagenomic sequencing market in terms of value. This can be attributed to factors such as developed healthcare systems, rising healthcare expenditure, growing genomics research funding, and presence ofleading market players in the region.
The Asia Pacific region is expected to grow at the fastest rate during the forecast period. This fast growth can be attributed to increasing healthcare investments, expanding base of genomic and biotechnology companies, growing public and private research funding, rising disposable incomes, and growing awareness about personalized medicine in emerging Asia Pacific countries.
What are the key data covered in this Global Metagenomic Sequencing Market report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Metagenomic Sequencing Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Metagenomic Sequencing Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behavior
:- Global Metagenomic Sequencing Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Metagenomic Sequencing Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Metagenomic Sequencing market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Metagenomic Sequencing Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Metagenomic Sequencing market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
- Source: CoherentMI, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
